FibroGen's loss under GAAP for 9 months of 2020 was $130.657 million, compared to a profit of $21.153 million in the previous year. Revenue decreased 2.2 times to $111.32 million, compared to $248.603 million a year earlier.
FibroGen's loss under GAAP for 9 months of 2020 was $130.657 million, compared to a profit of $21.153 million in the previous year. Revenue decreased 2.2 times to $111.32 million, compared to $248.603 million a year earlier. 
fibrogen.gcs-web.com
English (US) 